欧洲的生育保护实践和胃肠道瘤学家:一项泛欧洲研究

Irit Ben-Aharon1,2, Tal Goshen-Lago1, Alberto Puccini3,4

  • 1Division of Oncology, Rambam Health Care Campus, Haifa 31096, Israel.

The oncologist
|November 8, 2025
PubMed
概括

在欧洲的胃肠道 (GI) 瘤学家中,生育保存的讨论和实践在很大程度上存在差异. 许多瘤学家并不总是为年轻的胃肠道癌患者提供生育能力保护 (FP) 选择,这凸显了改善教育和标准化护理的需要.

相关概念视频

Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
519
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
3.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K